Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 10;23(1):2217.
doi: 10.1186/s12889-023-17095-4.

Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study

Affiliations

Factors for hesitancy towards vaccination against COVID-19 among the adult population in Puducherry, India - a cross sectional study

Raja Jeyapal Dinesh et al. BMC Public Health. .

Abstract

Background: Vaccine hesitancy is a complex phenomenon that threatens global health. Present-day communication technology has paved the way for self-education but also contributed to the infodemic surrounding vaccination. This has resulted in pockets of people who are reluctant, refuse recommended vaccinations, or choose to delay being vaccinated. The present study was designed to estimate the magnitude of hesitancy towards the COVID-19 vaccination and determine its associated factors in the community.

Methods: This cross-sectional study was conducted among 776 adults aged ≥ 18 years in 15 clusters in Puducherry district, India, between March 2022 and May 2022. Face-to-face interviews were conducted using a validated, structured questionnaire. Socio-demographic variables, co-morbidities, attitudes towards vaccination, etc., were expressed as frequencies and percentages. Vaccine hesitancy was dichotomized with the median score as the cut-off and reported as a proportion with a 95% confidence interval. Univariate and multivariate analyses were carried out to determine the factors associated with vaccine hesitancy.

Results: The mean age of participants was 43.3 ± 14.8 years, with the majority being female (67.0%). Nearly 92.4%, 74.4%, and 0.5% of participants received their first, second, and precautionary doses, respectively, during the study period. Among the unvaccinated, 93.2% were unwilling to receive any dose of vaccination. More than half of the participants were hesitant towards vaccination, according to the vaccine hesitancy scale. Participants aged above 45 years were less hesitant, while those educated up to school level, belonging to the upper socio-economic class, never tested for COVID-19 in the past, and having a negative attitude towards vaccination were significantly associated with higher vaccine hesitancy.

Conclusions: It is imperative to address vaccine hesitancy by alleviating existing fears and misconceptions in the community through efficient communication strategies to win the fight against current as well as future public health emergencies.

Keywords: COVID-19; Pandemic; Vaccination; Vaccine Hesitancy.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare that are relevant to the content of this article.

Figures

Fig. 1
Fig. 1
Map showing study areas in Puducherry district
Fig. 2
Fig. 2
Sampling method
Fig. 3
Fig. 3
COVID-19 vaccination status and willingness for vaccination

References

    1. Kapoor A, Goyal S. India’s COVID 19 Vaccine Administration Journey: an overview. 2022. https://competitiveness.in/wp-content/uploads/2022/02/Report_2_Vaccinati.... Accessed 25 May 2023
    1. Bhatnagar T, Chaudhuri S, Ponnaiah M, et al. Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study. Int J Infect Dis. 2022;122:693–702. 10.1016/j.ijid.2022.07.033. Epub 2022 Jul 16. PMID: 35843496; PMCID: PMC9288262. - PMC - PubMed
    1. Abhilash KPP, Mathiyalagan P, Krishnaraj VRK, et al. Impact of prior vaccination with CovishieldTM and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study. Vaccine. 2022;40(13):2107–2113. 10.1016/j.vaccine.2022.02.023. Epub 2022 Feb 10. PMID: 35168837; PMCID: PMC8828422. - PMC - PubMed
    1. CoWIN. Ministry of health and family welfare, Government of India. https://dashboard.cowin.gov.in/ Accessed 25 May 2023.
    1. Covid-19 vaccine hesitancy: trends across states, over time. April, 2021. https://www.ideasforindia.in/topics/governance/covid-19-vaccine-hesitanc... Accessed 25 May 2023.

Publication types

Substances